Navigation Links
First Town Hall Meeting on Inequities in Clinical Trials to Take Place at the Harlem Hospital Center on October 20
Date:10/15/2008

Community Leaders/Patients Encouraged to Discuss Challenges; Offer Solutions

NEW YORK, Oct. 15 /PRNewswire-USNewswire/ -- On the heels of a major report revealing that the vast majority of Americans -- and especially women, older people and racial and ethnic minorities -- are either under-represented or completely excluded from the medical studies for diseases from asthma to cancer, Harlem Hospital Center will host a town hall on Monday, October 20 so local leaders, patients, family members and health professionals from the five boroughs can offer their ideas on how to reduce disparities in clinical trials at the community level. The forum will be held in the Herbert G. Cave Auditorium at the Harlem Hospital Center (second floor) from 5 pm to 8 pm.

The first of eight Regional Dialogues to be held in the U.S. and Puerto Rico, the Harlem town hall is part of the EDICT (Eliminating Disparities in Clinical Trials) Initiative, which for the last three years has been advancing solutions so more qualified Americans can take part in important medical studies. EDICT is spearheaded by the Chronic Disease Prevention and Control Research Center (CDPCRC) at Baylor College of Medicine in Houston and the Intercultural Cancer Council (ICC), working to eliminate the unequal burden of cancer among racial and ethnic minorities and medically underserved populations.

Coming at a time when less than one percent of the entire U.S. population -- or an estimated 2.3 million Americans -- takes part in the 80,000 medical research studies conducted every year in the U.S., the Harlem town hall will confront one of the major barriers impeding clinical research: communities are usually left out of the clinical trials process. According to the report issued by EDICT in April 2008, lack of community participation in the clinical trials process is a major reason that the makeup of research studies does not mirror those in the population with the highest rates of disease.
'/>"/>

SOURCE Eliminating Disparities in Clinical Trials
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
7. Tainted Chinese Food Ingredients First Discovered in 2005
8. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... LOS ANGELES , Sept. 19, 2014  CytRx ... and development company specializing in oncology, today announced that ... will present at BioCentury,s 2014 NewsMakers in the Biotech ... p.m. Eastern Time. The conference will take place at ... City . A live and archived ...
(Date:9/19/2014)... -- Reductions in kidney failure obtained during ... with diabetes type 2 "Intensive treatment is ... kidneys." Australian researchers have discovered that intensive ... to persistent reductions in kidney failure many years after ... has found that, five and a half years after ...
(Date:9/18/2014)... , September 19, 2014 ... Markets ( http://www.researchandmarkets.com/research/qqjrnh/global_molecular ) has announced the ... Market 2014-2018" report to their offering. ... Cytogenetics involves the study of chromosomes using ... functions of genes and chromosomes. It plays ...
Breaking Medicine Technology:CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 3ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 2ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 3Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 2Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 3
... Audax Medical, Inc. ( www.audaxmed.com ), a privately held ... has been awarded a research and development grant through ... was established under the Patient Protection and Affordable Care ... innovative, reduce long-term healthcare costs, and/or address unmet medical ...
... 2010 The American Heart Journal today ... lead product candidate, AMR-001 for the treatment of damaged ... a significant relationship between cell dose and biologic effect. ... define a dose of a purified and potent autologous ...
Cached Medicine Technology:Audax Medical, Inc. Receives Therapeutic Discovery Grant for Development of Regenerative Bone Material 2Amorcyte Stem Cell Therapy Demonstrates Clinically Significant Reperfusion in Severe Heart Attack Patients 2Amorcyte Stem Cell Therapy Demonstrates Clinically Significant Reperfusion in Severe Heart Attack Patients 3
(Date:9/20/2014)... (PRWEB) September 20, 2014 New ... and Market Analysis to 2023?. The asthma market ... as it has become saturated with relatively efficacious ... corticosteroids (ICSs), inhaled corticosteroids and long-acting beta-agonists (ICS/LABAs), ... increasing generic competition. However, the launch of seven ...
(Date:9/20/2014)... Recently, Best Cheap Hosting USA (best-cheap-hosting-usa.com), a ... website. The new site provides the latest reviews ... customers. Here, people can find a lot of ... it has recommended some excellent web hosting suppliers ... great web hosting suppliers, InMotion ( http://www.best-cheap-hosting-usa.com/go/InMotion/ ), ...
(Date:9/20/2014)... September 20, 2014 "As a nurse, patients ... tanks," said an inventor from Tamaqua, Pa. "The reason that ... the backs of their chairs. My invention enables them to ... Kam Oxygen Sensor to make it easier to monitor the ... user knows when the tank is low. It allows changeovers ...
(Date:9/20/2014)... Earlier this week, Home Depot revealed that up to ... card information pilfered by hackers, surpassing the 40 million Target ... articles like this one published by Bloomberg on September ... , “Most people tend to focus on how many credit ... score a game,” says Joe Caruso, founder and CEO/CTO of ...
(Date:9/20/2014)... September 20, 2014 Final Cut Pro ... the release of the Information theme for FCPX filmmakers. , ... to describe the Information theme,” says Christina Austin, CEO of ... look so professional.” , Information features easy to use controls ... of the environment. Change the background color, color of each ...
Breaking Medicine News(10 mins):Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 2Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 3Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 4Health News:Best Cheap Hosting USA Launches Its New Website And Recommends InMotion To Worldwide People 2Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 2Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 3Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 4Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 5Health News:Today Pixel Film Studios Announced the Release of the Information Theme for Final Cut Pro X 2
... to the latest on breast-feeding, there is no hard and ... newborn. Most young mothers would be more// than glad ... while breast feeding, can prove too painful for motherly feelings ... Adolphe. Nicola accordingly, had a horrendous time trying to breastfeed ...
... prince donates his youth to his father so that he could ... is at hand now. For scientists say they have discovered a ... by manipulating that gene perhaps one could live longer, they hope. ... lifespan of animals that are subjected to a calorie-restricted diet -when ...
... Anti-depressants could indeed lift one out of depression. But ... been recognized//. ,Now the U.S. Food and ... antidepressant medications update the existing black box warning on ... of suicidal thinking and behavior, in young adults ages ...
... pregnancy, migraine and stroke, US researchers said. The combination ... fact, Cheryl Bushnell, assistant professor of neurology at the ... that pregnant women who suffered migraine carried a risk ... did not suffer migraine. ,Elaborating on the ...
... know that older women - those 80 or older - have ... published today. ,Worryingly, the research also found that 56 ... breast cancer risk. ,The strongest risk factor for breast ... higher her risk. About one in 70 women will develop breast ...
... of moderate to severe chronic obstructive pulmonary disease//, or ... ,The results of the randomized, double-blind, placebo-controlled trial of ... May American Journal of Respiratory and Critical Care Medicine, ... to an editorial commenting on the research, the failure ...
Cached Medicine News:Health News:New Research Promises To Take The Pain Off Breast Feeding 2Health News:New Research Promises To Take The Pain Off Breast Feeding 3Health News:Gene Responsible for Ageing Process Discovered – and Calorie Restriction Could Hel 2Health News:FDA Advisory Against Anti-depressants to Be Expanded to Cover Young Adults too 2Health News:FDA Advisory Against Anti-depressants to Be Expanded to Cover Young Adults too 3Health News:Women Unaware of When Breast Cancer Risk is Greatest 2Health News:Anti-inflammatory Drug Fails to Improve COPD Symptoms 2
Human based material available in two levels for the control of accuracy and precision for upto 23 analytes....
Human based assayed sera available in three levels for the control of accuracy and precision for up to 25 analytes...
The AMY method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of amylase activity in serum, plasma and urine....
Enzymatic Clearance assay for the in vitro quantitative determination of LDL-cholesterol in human serum and plasma....
Medicine Products: